持続可能な医薬品製造のためのデジタルデザインによる品質による人工知能の統合
Rand Abdulhussain1, Haja Muhamad1, Toaha Fiza1
1Department of Pharmacy, University of Huddersfield, Huddersfield HD1 3DH, UK.
International journal of pharmaceutics
|February 16, 2026
まとめ
デジタルデザインによる品質 (Quality by Digital Design, QbDD) に人工知能 (AI) を統合することで,製薬製造業に革命が起こります. このデジタルアプローチは,リアルタイムモニタリングと予測制御を通じて,医薬品の品質,効率,持続可能性を向上させます.
科学分野:
- 製薬製造業 製薬製造業
- デジタルトランスフォーメーション デジタルトランスフォーメーション
- 人工知能 (AI) とは,人工知能 (AI) のことです.
背景:
- 製薬業界は,製品の品質,製造効率,および環境の持続可能性を改善するために,重要なデジタルトランスフォーメーションを経験しています.
- デザインによる品質 (Quality by Design, QbD) の伝統的な原則は,デジタル技術の統合とともに進化しています.
研究 の 目的:
- デジタルデザインによる品質 (QbDD) フレームワークにおける人工知能 (AI) の統合を調査する.
- 医薬品製造における伝統的なQbDアプローチの進化として,QbDDの可能性を検証する.
- 製薬部門における持続可能性の促進におけるAIの役割を評価する.
主な方法:
- AIとQbDDに関する現在の文献と業界慣行のレビュー.
- AI,機械学習,デジタルツイン,および医薬品開発と製造の最適化における高度なデータ分析の分析.
- エネルギー最適化,廃棄物削減,予測保守,サプライチェーン効率化のためのAIアプリケーションの検討.
主要な成果:
- デジタルデザインによる品質 (Quality by Digital Design, QbDD) は,AIとデジタルツールを活用して,デザインスペース,重要な品質属性,リアルタイムリリーステストなどのキーコンポーネントを再定義します.
- AIは,リアルタイムモニタリングと予測分析を通じて,積極的かつ適応的なプロセス制御を可能にします.
- AIのアプリケーションは,エネルギー節約と廃棄物の削減を含む,医薬品製造における持続可能性の向上のための重要な可能性を実証しています.
結論:
- AI対応のQbDDは,従来のQbDよりも重要な進歩であり,強化された制御と最適化を提供します.
- 実施の成功には,規制の整合,データの完全性,人材の育成などの課題に取り組む必要がある.
- 持続可能な製薬製造におけるAIのより広範な採用は,将来的に大きな機会をもたらします.
関連する概念動画
Biopharmaceutical Factors Influencing Drug Product Design: Overview
320
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
320
Issues And Trends In Healthcare Delivery System
6.3K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
6.3K
Structure-Activity Relationships and Drug Design
1.9K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.9K
Quality Assurance
3.0K
Quality assurance is the overarching term used to describe the activities employed to ensure the proper performance of a system. These activities can be classified into three categories: quality control, quality assessment, and internal corrective measures. Typically, these activities work cyclically: quality control is performed before and during the analysis, while quality assessment occurs during and after the investigation. Internal corrective measures are implemented based on the findings...
3.0K
In Vitro Drug Release Testing: Overview, Development and Validation
379
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
379
Biopharmaceutics and Pharmacokinetics: Overview
4.4K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
4.4K


